Bora Pharmaceuticals

Activities: Manufacturing Research & Development Pharmaceutical

Trending Articles

  1. Thermo Fisher Scientific officially opens US oral solid dose testing and R&D facility The company's further expansion in the Bend, Oregon area will assist its pharmaceutical clients in the early development of oral solid dosage (OSD) forms
  2. Stablepharma and AJ Vaccines to sign a distribution deal for SPVX02 AJ Vaccines will be responsible for the distribution and commercialisation of the fridge-free adult booster vaccine for tetanus and diphtheria across Europe
  3. Reckitt expands US OTC manufacturing footprint with North Carolina facility The site in Wilson will be responsible for producing Mucinex® branded tablets and liquids, which are designed as over the counter (OTC) medicines for cold and flu symptoms
  4. Modular automated flow synthesis of spirocyclic THNs from primary alkylamines Asynt and the Cresswell Group achieve advances in drug discovery scaffolds
  5. Amgen invests $1bn into new US drug manufacturing facility The site will be the CDMO's second drug substance manufacturing facility in North Carolina, and will boost its presence in the US pharmaceutical market

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Manufacturing

Bora Pharmaceuticals and Tanvex partner to provide global biologics CDM services

The companies will collaborate to enhance their offerings in the biologics development and manufacturing market
Manufacturing

Bora Pharmaceuticals increases US footprint with sterile manufacturing facility

This bolsters Bora's US fill/finish capabilities for sterile injectables
Manufacturing

Bora Pharmaceuticals to acquire US pharma manufacturer Upsher-Smith for $210 Million

Combined, the two manufacturing facilities in Minnesota are capable of commercialising a broad range of dosage forms
Manufacturing

Bora opens facility for Ophthalmic manufacturing

The facility will provide Bora’s customers with access to an extensive range of ophthalmic manufacturing service
Regulatory

Bora and Celltrion team up on oral dosage form drugs

The range of oral dosage form products will be manufactured at Bora’s Zhunan Site, one of the largest pharmaceutical production facilities in Taiwan
Manufacturing

Bringing performance, quality and safety to the pharmaceutical industry

Catching up with a trio of industry outsourcing experts, Dr Kevin Robinson explores the key trends have had the biggest impact on the pharmaceutical’s contract service industry in recent times
Drug Delivery

Bora and TaiRx to manufacture anticancer drug

The novel anticancer drug CVM-1118 is a new small molecule chemical entity being developed by TaiRx
Subscribe now